Edited by Dentaltown staff
MELVILLE, NY – Henry Schein recently announced the availability of an antibody rapid blood test known as Standard Q COVID-19 IgM/IgG Rapid Test, intended to be administered at the point of care. The test delivers results within 15 minutes from a pinprick with no instrumentation required.
This test is a rapid immunochromatography test designed for the qualitative presumptive detection of specific IgM and IgG antibodies associated with the 2019 novel coronavirus (SARS-CoV-2) in blood drawn with a pinprick. The test is being made available under emergency guidance issued by the U.S. Food and Drug Administration (FDA).
Health care professionals can use the results of the test, along with a patient’s medical history, symptoms, and results of other relevant testing, to make informed decisions about patient treatment and care.
Henry Schein is working through multiple channels to distribute the tests in the United States in response to the urgent need for rapid, accurate testing. The company anticipates having at least several hundred thousand tests available by March 30 and significantly increased availability beginning in April and plans to make the Standard Q COVID-19 test available for use by physician offices, hospitals, and other relevant health care institutions.
To learn more visit www.henryschein.com/COVID19update